Mar Martín‐Pérez

机构：Agencia Española de Medicamentos y Productos Sanitarios · ORCID：0000-0002-5376-2549

发表论文 44 篇 · 总被引 835 次 · h-index 15

代表论文

Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study (2022 · Vaccine · 被引 74)
Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries (2022 · Frontiers in Pharmacology · 被引 30)
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study (2023 · Drug Safety · 被引 26)
Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries (2023 · Vaccine · 被引 23)
Background Rates of 41 Adverse Events of Special Interest for COVID-19 Vaccines in 10 European Healthcare Databases - An ACCESS Cohort Study (2022 · SSRN Electronic Journal · 被引 10)
Multiple vertebral fractures after antiosteoporotic medications discontinuation: A comparative study to evaluate the potential rebound effect of denosumab (2024 · Bone · 被引 7)